| 1 | Name: | Dr. Corey S. Goodman | |
| Institution: | venBio Partners LLC; University of California, Berkeley | ||
| Year Elected: | 1999 | ||
| Class: | 2. Biological Sciences | ||
| Subdivision: | 208. Plant Sciences | ||
| Residency: | Resident | ||
| Living? : | Living | ||
| Birth Date: | 1951 | ||
Corey Goodman was named president of Pfizer's Biotherapeutics and Bioinnovation Center in 2007. Prior to this appointment, he was president and CEO of Renovis, a neuroscience biopharmaceutical company he helped co-found in 2000. Dr. Goodman received his B.S. degree in biology from Stanford University in 1972, and his Ph.D. degree in neurobiology from the University of California, Berkeley in 1977. From 1977 to 1979 he was a Helen Hay Whitney Postdoctoral Fellow at U.C. San Diego. Beginning in 1979 he was a faculty member in the Department of Biological Sciences at Stanford University, receiving tenure in 1982. In 1987 he joined the faculty at the University of California at Berkeley, where he was an Investigator with the Howard Hughes Medical Institute, Evan Rauch Professor of Neuroscience, and Director of the Wills Neuroscience Institute. Dr. Goodman is a world leader in the understanding of the molecules and mechanisms that control nerve growth and guidance, and their implications for nerve restoration and repair. In 2001, he became President and CEO of Renovis. He is also President of the McKnight Endowment Fund for Neuroscience, and Chair of the National Research Council's Board on Life Sciences. Prior to co-founding Renovis, Dr. Goodman co-founded Exelixis in 1994. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society. Amongst his many scientific honors is the Alan T. Waterman Award for Achievement in Medical Sciences in 1997, and the March-of-Dimes Prize in Developmental Biology in 2001. | |||